Actively Recruiting
Comparison of the Effectiveness of the Simple Puncture Compared to the Incision of an Abscess on the PiLOnidal Sinus
Led by University Hospital, Angers · Updated on 2025-03-26
134
Participants Needed
1
Research Sites
148 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pilonidal disease is a common disease characterized by the presence of abscess in the intergluteal groove. During periods of abscess, current recommendations are to make a simple incision with daily wicking of the abscess. Direct excision at this time is not recommended because there is a risk of incomplete excision. The principle of directed healing after incision of the abscess results in an average dressing period of 21 days. A definitive resection is recommended after 4 to 6 weeks, when healing has been achieved, in order to limit the risk of infectious recurrence. An alternative has recently been proposed, consisting of a puncture of the abscess, aimed at emptying it under antibiotic coverage. The major advantage of this treatment is that patients no longer need general anesthesia to flatten the abscess. Although this technique is promising, it is currently not the subject of any published or ongoing randomized controlled study registered on Clinicaltrials.gov. The research hypothesis is that the two techniques have the same results in terms of recurrence before definitive surgical treatment but that drainage puncture would imply a faster healing time, a lower cost of treatment, a quality of superior support, reduced support time and reduced work stoppage.
CONDITIONS
Official Title
Comparison of the Effectiveness of the Simple Puncture Compared to the Incision of an Abscess on the PiLOnidal Sinus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with a pilonidal sinus abscess
- Surgical indication for flattening the abscess
- Recurrent or new abscess
- Signed consent to participate in the study
You will not qualify if you...
- Antibiotic therapy started before the consultation
- Presence of skin necrosis
- Immunosuppression or diabetes
- Spontaneous fistulization
- Patients who do not speak French
- Pregnant or breastfeeding women
- Patients without social security coverage
- Persons deprived of liberty by judicial or administrative decision
- Persons under psychiatric care against their will
- Persons under legal protection
- Persons unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Angers
Angers, France, 49000
Actively Recruiting
Research Team
A
Aurélien VENARA, PHD
CONTACT
A
Aurélien VENARA, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here